Thrombosis on a left atrial appendage occluder device: the double-edged sword of stroke prevention strategies in atrial fibrillation

J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):920-921. doi: 10.2459/JCM.0000000000000570.

Abstract

: A huge thrombus, developing after percutaneous left atrial appendage occlusion, has been successfully treated with dabigatran and aspirin as combination therapy.Although novel oral anticoagulants alone may be effective in thrombus dissolution, the association of an antiplatelet drug may safely enhance this process.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use
  • Aspirin / therapeutic use
  • Atrial Appendage / surgery*
  • Atrial Fibrillation / therapy*
  • Dabigatran
  • Echocardiography, Three-Dimensional
  • Humans
  • Male
  • Septal Occluder Device / adverse effects*
  • Stroke / prevention & control*
  • Thrombosis / etiology
  • Thrombosis / therapy*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Dabigatran
  • Aspirin